Eckert & Ziegler SE (LON:0NZY)

Market Cap	1.20B
Revenue (ttm)	247.98M
Net Income (ttm)	28.84M
Shares Out	n/a
EPS (ttm)	1.37
PE Ratio	41.60
Forward PE	25.13
Dividend	0.43 (0.63%)
Ex-Dividend Date	Jun 19, 2025

Volume	58
Average Volume	4,003
Open	66.73
Previous Close	66.05
Day's Range	65.90 - 67.10
52-Week Range	36.88 - 69.20
Beta	1.57
RSI	54.40
Earnings Date	Aug 8, 2025

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynt...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 2024
• Employees: 1,085
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NZY

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.

Financial numbers in EUR